- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: RAD001 (Everolimus)
Total 1063 results
-
University of CincinnatiNovartisTerminated
-
Brian Hill, MD, PhDNational Cancer Institute (NCI); The Leukemia and Lymphoma SocietyTerminatedLymphoma | 714leukemiaUnited States
-
Children's Hospital Medical Center, CincinnatiNovartisCompletedTuberous Sclerosis | Subependymal Giant Cell AstrocytomaUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsCompletedUveal MelanomaUnited States
-
Novartis PharmaceuticalsCompletedPrevention of Acute Rejection in Paediatric Recipients of a Renal TransplantGermany, United Kingdom, France, Italy, United States, Hungary, Norway, Spain, Argentina, Brazil, Poland, Sweden, Turkey
-
SCRI Development Innovations, LLCNovartis PharmaceuticalsCompletedProstate CancerUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); NovartisCompleted
-
Novartis PharmaceuticalsCompletedTuberous Sclerosis | Subependymal Giant Cell AstrocytomaUnited States, Belgium, Canada, Germany, Italy, Russian Federation, Netherlands, Poland, Australia, United Kingdom
-
howard safranThe Miriam Hospital; Rhode Island Hospital; Memorial Hospital of Rhode Island; Roger...TerminatedHead and Neck CancerUnited States
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital and other collaboratorsCompletedGastrointestinal CancerUnited States
-
Hoffmann-La RocheTerminated
-
NYU Langone HealthNovartis PharmaceuticalsCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)TerminatedLung Cancer | Metastatic CancerUnited States
-
Annick DesjardinsNovartis PharmaceuticalsCompletedGlioblastoma | GliosarcomaUnited States
-
Children's Hospital Medical Center, CincinnatiNovartis PharmaceuticalsCompletedTuberous Sclerosis | LymphangioleiomyomatosisUnited States
-
Novartis PharmaceuticalsActive, not recruitingTuberous Sclerosis ComplexUnited States, Spain, Belgium, Taiwan, Turkey, Australia, Korea, Republic of, Thailand, France, Hungary, United Kingdom, Italy, Japan, Canada, Russian Federation, Poland, Mexico, Colombia
-
M.D. Anderson Cancer CenterNovartis PharmaceuticalsCompletedSystemic MastocytosisUnited States
-
Emory UniversityNovartisCompletedThyroid CancerUnited States
-
Novartis PharmaceuticalsCompletedCD79 Mutant or ABC-subtype Diffuse Large B-Cell LymphomaTaiwan, Italy, Netherlands, Hong Kong, Germany, United States, Korea, Republic of, France
-
German Breast GroupNovartisUnknown
-
Anne Beaven, MDNovartisTerminatedDiffuse Large B-cell LymphomaUnited States
-
Children's Hospital Medical Center, CincinnatiNovartisCompletedEpilepsy | Tuberous Sclerosis ComplexUnited States
-
SCRI Development Innovations, LLCBayer; NovartisCompletedKidney CancerUnited States
-
Assistance Publique - Hôpitaux de ParisCompleted
-
M.D. Anderson Cancer CenterNovartis Pharmaceuticals; BTG International Inc.Withdrawn
-
National University Hospital, SingaporeTerminated
-
Dana-Farber Cancer InstituteNovartis PharmaceuticalsCompletedTuberous Sclerosis Complex | TSC1 | TSC2 | MTORUnited States
-
Beth Israel Deaconess Medical CenterDana-Farber Cancer Institute; Novartis PharmaceuticalsCompleted
-
Seoul National University HospitalCompletedPheochromocytoma | Extra-adrenal Paraganglioma | Non-functioning CarcinoidKorea, Republic of
-
Gerhard TreiberCrolll Gmbh; Janssen Diagnostics, LLC; Estimate, GmbHCompletedHepatocellular CarcinomaGermany
-
Seung-Jung ParkAbbott Medical Devices; CardioVascular Research Foundation, KoreaTerminatedCoronary Artery DiseaseThailand, Korea, Republic of, China, Malaysia
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsTerminatedNeuroma, Acoustic | Neurofibromatosis Type 2United States
-
Novartis PharmaceuticalsCompletedCarcinomaChina, Italy, Taiwan, Germany, Hungary, Belgium, Spain, Australia, Austria, France, Hong Kong, Thailand, Korea, Republic of, Canada, Japan, Israel, United States, Greece
-
Daniel George, MDNovartisCompletedKidney Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Emory UniversityGenentech, Inc.; Novartis PharmaceuticalsCompletedBreast CancerUnited States
-
Swiss Group for Clinical Cancer ResearchCompletedLiver CancerSwitzerland, Austria, Hungary
-
Novartis PharmaceuticalsCompletedMetastatic Renal Cell Carcinoma | Advanced Solid Tumors | Metastatic Breast CancerSpain, Belgium, Italy, France, United States, New Zealand, United Kingdom
-
Dana-Farber Cancer InstituteNovartis; Brigham and Women's HospitalTerminatedHead and Neck CancerUnited States
-
University of CologneCompletedNon-Small Cell Lung Cancer | Unspecified Adult Solid Tumor, Protocol SpecificGermany
-
National Cancer Center, KoreaTerminatedMetastatic Breast CancerKorea, Republic of
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Heinrich-Heine University, DuesseldorfTerminated
-
Novartis PharmaceuticalsCompletedNeuroendocrine Tumors | Advanced NET of GI Origin | Advanced NET of Lung OriginUnited States, Colombia, Italy, Taiwan, United Kingdom, Belgium, Czechia, Germany, Japan, Saudi Arabia, Canada, Netherlands, Spain, Korea, Republic of, Lebanon, Austria, China, Greece, South Africa, Thailand, Hungary, Turkey, Poland, ... and more
-
GERCOR - Multidisciplinary Oncology Cooperative...Completed
-
Herbert Hurwitz, MDNovartis; Genentech, Inc.; AmgenCompleted
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedBreast CancerUnited States
-
Richard Stone, MDMassachusetts General Hospital; Novartis; Beth Israel Deaconess Medical Center; Brigham and Women's HospitalActive, not recruitingRAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDSAcute Myeloid Leukemia | Myelodysplastic SyndromeUnited States
-
Duke UniversityNovartis; PfizerCompletedAdvanced Non-clear Cell Renal Cell CarcinomaUnited States, Canada, United Kingdom
-
Novartis PharmaceuticalsCompletedRenal Cell CarcinomaCanada, United Kingdom, Hong Kong, Netherlands, United States, Thailand, Korea, Republic of, Spain, Australia, Denmark, Mexico, Germany, Turkey, Italy, France, Brazil, Peru, Taiwan, Argentina
-
University of PittsburghGenentech, Inc.; Novartis PharmaceuticalsCompletedStudy of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer (RADBEV)Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal CarcinomaUnited States